Next-generation cell-penetrating antibodies for tumor targeting and RAD51 inhibition
Madison Rackear(Yale University), Peter M. Glazer(Yale University)
Cited by 7
Related Papers
In vivo correction of anaemia in β-thalassemic mice by γPNA-mediated gene editing with nanoparticle delivery
|Nature Communications|2016|183
Potentiation of Temozolomide Cytotoxicity by Inhibition of DNA Polymerase β Is Accentuated by BRCA2 Mutation
|Cancer Research|2009|34
Synthetic lethality of a cell-penetrating anti-RAD51 antibody in PTEN-deficient melanoma and glioma cells
|Oncotarget|2019|31
Harnessing exDNA for precision exatecan delivery in cancer: a novel antibody-drug conjugate approach
|Molecular Cancer|2025|3
Tumor-Specific Antigen Delivery for T-cell Therapy via a pH-Sensitive Peptide Conjugate
|Molecular Cancer Therapeutics|2024|2